Dexcom has released results from a recent clinical trial that suggest continuous glucose monitoring (CGM) may offer significant benefits for a broader population of diabetes patients.
This development is part of a larger conversation around advancements in health technology, which also includes updates from Apple's recent developers' conference.
As the landscape of diabetes management evolves, the implications of these findings could be substantial for both patients and healthcare providers.